Beclomethasone dipropionate in Crohn's ileitis: A randomised, double-blind trial

Digestive and Liver Disease

Volumn 43, Issue 6, 2011, Pages 459-464

  Prantera, Cosimo ^a   Rizzi, Marina ^a   Cottone, Mario ^b   Casa, Angelo ^b   Annese, Vito ^c   Sturniolo, Giacomo Carlo ^d   Marconi, Stefano ^e   Lochs, Herbert ^f  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e CHIESI FARMACEUTICI S P A   (Italy)

^f UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Beclomethasone dipropionate; Crohn's disease; Remission

Indexed keywords

BECLOMETASONE DIPROPIONATE; PLACEBO; PREDNISONE;

ADULT; AGED; ARTICLE; BLOOD DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CROHN DISEASE; CUSHING SYNDROME; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HEPATOBILIARY DISEASE; HUMAN; HYPERTHYROIDISM; ILEITIS; INFECTION; INFESTATION; KIDNEY DISEASE; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM DISEASE; MENTAL DISEASE; MESENTERY DISEASE; MOON FACE; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; REMISSION; RESPIRATORY TRACT DISEASE; SKIN DISEASE; THORAX DISEASE; TREATMENT REFUSAL; UNSPECIFIED SIDE EFFECT; UROGENITAL TRACT DISEASE; VASCULAR DISEASE;

ADULT; AGED; BECLOMETHASONE; CROHN DISEASE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PREDNISONE; RECURRENCE; REMISSION INDUCTION; TABLETS, ENTERIC-COATED; TREATMENT OUTCOME;

EID: 79955922869     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.12.001     Document Type: Article

References (20)

1. Kornbluth A., Sachar D.B. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004, 99:1371-1385.
2. Carter M.J., Lobo A.J., Travis S.P. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004, 53 Suppl. 5:V1-V16.
3. Dignass A., Van Assche G., Lindsay J.O., et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohn Colitis 2010, 4:28-62.
4. Summers R.W., Switz D.M., Sessions J.T., et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979, 77:847-869.
5. Modigliani R., Mary J.Y., Simon J.F., et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology 1990, 98:811-818.
6. Ardizzone S., Bianchi Porro G. Comparative tolerability of therapies for ulcerative colitis. Drug Saf 2002, 25:561-582.
7. Irving P.M., Gearry R.B., Sparrow M.P., et al. Review article: appropriate use of corticosteroids in Crohn's disease. Aliment Pharmacol Ther 2007, 26:313-329.
8. Lichtenstein G.R., Bengtsson B., Hapten-White L., Rutgeerts P. Oral budesonide for maintenance of remission of Crohn's disease: a pooled safety analysis. Aliment Pharmacol Ther 2009, 29:643-653.
9. Greenberg G.R., Feagan B.G., Martin F., et al. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study Canadian Inflammatory Bowel Disease Study Group. Gastroenterology 1996, 110:45-51.
10. Lofberg R., Rutgeerts P., Malchow H., et al. Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut 1996, 39:82-86.
11. Benchimol E.I., Seow C.H., Otley A.R., et al. Budesonide for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2009, CD002913.
12. Campieri M. New steroids and new salicylates in inflammatory bowel disease: a ritical appraisal. Gut 2002, 50 Suppl. 3:III43-III46.
13. Campieri M., Adamo S., Valpiani D., et al. Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study. Aliment Pharmacol Ther 2003, 17:1471-1480.
14. Rizzello F., Gionchetti P., D'Arienzo A., et al. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2002, 16:1109-1116.
15. Rizzello F., Gionchetti P., Galeazzi R., et al. Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: a dose-finding study. Adv Ther 2001, 18:261-271.
16. Astegiano M., Pagano N., Sapone N., et al. Efficacy and safety of oral beclomethasone dipropionate for ileal or ileal-right colon Crohn's disease of mild-to-moderate activity or in remission: retrospective study. Biomed Pharmacother 2007, 61:370-376.
17. Pharmaceuticals T-C. CLIPPER summary of product characteristics; 2007.
18. Benchimol E.I., Seow C.H., Steinhart A.H., et al. Traditional corticosteroids for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2008, CD006792.
19. Rutgeerts P., Lofberg R., Malchow H., et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994, 331:842-845.
20. Henzen C., Suter A., Lerch E., et al. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet 2000, 355:542-545.